Cramer's Morning Take: Bond Market vs. Stock Market 10/10/23

SPEAKER_1 (0:00)

What do you see on the horizon? Uncertainty or opportunity? Whatever you see, at PGM, we can help you rise to the challenges of today, providing outlooks on the market with deep global and local expertise.

With over 1,400 investment professionals in pursuit of long-term returns, our investments shape tomorrow, today. Pursue your tomorrow with PGM, a leading global asset manager.

Jim Cramer (0:33)

Jim Cramer here to share with you a sample of my take on the market from today's CNBC Investing Club morning meeting.

Interest rates have been soaring, okay? And the reason why it's so discouraging and scary to people is that it never stops. This decline in yield, increase in bonds, is what I want. I want a stop-start, stair-step increase, because it's the straight-line velocity that matters. And people seem to forget it's the velocity that controls the fear. If you have a, you know, kind of goes back down, goes up, then you're going to get a market like we have today.

Jeff Marks (1:15)

You want the stairs in either direction versus, say, the escalator or, at worst, the elevator.

Jim Cramer (1:21)

Right. And, you know, it is, when you see a historic rally, what you say is there's something very wrong. You know, Neil Ferguson writes, there's something very wrong. You listen to Paul Tudor Jones, something very wrong. Now, there's been something, here's a little, I'm 68 Wow, that's ridiculous.

And there's been something wrong pretty much all my life. I mean, I remember when we gave, some people in the defense, scientists, gave the H-bomb to Russia. And my parents said that was the worst thing that ever happened. So now they have the H-bomb and they can drop it on us. There was a fear in this country where you built fallout shelters. Now, that was bad time. I can come up with so many bad times. So when I hear bad times from people and they say fiscal bad time, they're missing the whole point. It's been bad the whole way. It's been bad since George Washington was our first president.

There's never been a good time.

So let's just put that on the table and focus on opportunity.

Jeff Marks (2:17)

Yeah, and I think if we're just having a more of a longer term conversation, that if you're looking for the best way to create wealth over the long term, it's the stock market. That's what historically it has been and historically it will likely will be as well.

Jim Cramer (2:33)

Join the CNBC Investing Club with Jim Cramer to catch my member exclusive morning minis every day at 10, 20 a.m. Visit cnbc.com/morningtake to become a member today. That's one word, morning take.

SPEAKER_4 (2:51)

All opinions expressed by Jim Cramer on this podcast and in connection with the CNBC Investing Club are solely Cramer's opinions and do not reflect the opinions of CNBC, NBC Universal, or their parent company or affiliates and may have been previously disseminated by Cramer on television, radio, internet, or another medium.

No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Cramer. The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment, or strategy. You should be aware of the risk of loss in following any strategy or investment discussed in the content from Cramer. To view the full CNBC Investing Club disclaimer, please visit cnbc.com forward slash investing club disclaimer.

SPEAKER_5 (3:35)

With Sotictu for moderate to severe plaxoriasis, you could show off your skin again. And you know what that means.

As a Tic-2 inhibitor, Sotictu is the only once daily pill of its kind for adults with moderate to severe plaxoriasis. Ask your dermatologist about Sotictu today and learn more at soclearlyyou.com. That's soclearlyyou.com.

Sotictu, Dicravicitinib, is a prescription treatment for adults with moderate to severe plaxoriasis who may benefit from systemic therapy or phototherapy. Don't take if you're allergic to Sotictu. Serious reactions can occur. Before treatment, get checked for infections, including tuberculosis. Sotictu can lower your ability to fight infections. Don't start if you have one. Serious infections, cancers including lymphoma, muscle problems and changes in certain labs have occurred. Tell your doctor if you have a history of these events or if you have an infection or symptoms like fever, sweats, chills, muscle aches or cough. Or if you have history of hepatitis B or C, liver or kidney problems, high triglycerides or had a vaccine or planned to. SO TIC-2 inhibits TIC-2, which is part of the JAK family. People 50 and older with heart disease risk factors who use a JAK inhibitor are at increased risk for certain side effects, sometimes fatal. It's unknown if SO TIC-2 has the same risks as JAK inhibitors.